Story perspectives
UK-US Deal Prevents Tariffs, Boosts NHS Drug Spending
12/1/2025
1 of 1
Story summary
- The United Kingdom (UK) and United States (US) have a deal to prevent tariffs on UK drug exports, contingent on Britain raising NHS spending on medicines by 25%.
- NHS drug spending rises for the first time in over 20 years.
- U.S. officials say the agreement addresses longstanding complaints about U.K. drug pricing that burden American patients.
- NHS thresholds will range from £25,000 to £35,000 per quality-adjusted life year (QALY).
